Results 191 to 200 of about 51,507 (268)

Drug-Induced Liver Injury Secondary to Endocrine Therapy With Aromatase Inhibitors: A Case Report. [PDF]

Cureus
Smith NJ, Watchalotone S, Sandhu S.
europepmc   +1 more source

Effectiveness of supervised vs brief counselling physical activity promotion interventions in breast cancer survivors on aromatase inhibitors: the PAC-WOMAN randomized controlled trial. [PDF]

Int J Behav Nutr Phys Act
Carraça EV, Rodrigues B, Franco S, Nobre I, Jerónimo F, Ilharco V, Silva PF, Palmeira AL, Silva MN.   +8 more
europepmc   +1 more source

Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen. [PDF]

Discov Oncol
Najdi T, Seif S, Damaj N, Kattan J.
europepmc   +1 more source

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients. [PDF]

Metabolites
Jing F, Jiang L, Cao Y, Tian M, Qiu J, Zhang J, Tang L, Lu R, Hu Y.   +8 more
europepmc   +1 more source

Steroidal Aromatase Inhibitor [PDF]

, 2020
openaire   +1 more source

Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). [PDF]

Pharmacol Res Perspect
Yuste MT, Sainz-Gil M, Escudero E, Marín P.   +3 more
europepmc   +1 more source

Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study. [PDF]

Breast Cancer Res
Liu PH, Tsai CF, Hsu YC, Wu CY, Yang HY.
europepmc   +1 more source

Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline <i>BRCA</i> Mutation. [PDF]

Cancers (Basel)
Lema L, Pérez-García JM, Blanch S, Balmaña J, García-Sáenz JÁ, Vegas EF, Jiménez B, de la Haba J, Campolier M, Shimizu E, Alcalá-López D, Sampayo-Cordero M, Cortés J, Llombart-Cussac A.   +13 more
europepmc   +1 more source

Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors. [PDF]

Clin Pract
Céspedes P, Martínez-Arnau FM, Torregrosa MD, Cauli O, Buigues C.   +4 more
europepmc   +1 more source

Synthesis, Characterization, and <i>In Vitro</i> and <i>In Silico</i> Studies of New Triazole Derivatives as Aromatase Inhibitors. [PDF]

Med Chem
Uzmez ZL, Osmaniye D, Ozkay Y, Kaplancıklı ZA.   +3 more
europepmc   +1 more source